WEST AFRICA WEEKLY
Global pharmaceutical giant Pfizer has shut down its commercial operations in Nigeria, rendering its commercial employees redundant, according to internal company correspondence obtained by West Africa Weekly.
Documents obtained indicate that affected employees received formal redundancy notifications, signalling a major restructuring of Pfizer’s business model in the country. The documents suggest that the company is moving forward with layoffs but has yet to finalise employee severance packages.
An email dated January 13, signed by Olubukola Oparinde, Manager People Experience, SSA Biopharma, acknowledged employee concerns during discussions about the shutdown and stated that further feedback from leadership would be provided. Employees were issued redundancy notification letters, which they were required to acknowledge, confirming that they had been informed of their job losses.
Further correspondence on January 15 instructed affected staff to sign off on the notifications, emphasising that these were not final redundancy agreements. The company also indicated that severance details were subject to additional approvals.
A follow-up email on February 12 addressed to an employee included severance computation details, suggesting that discussions around employee compensation were ongoing…
Connect with us on our socials: